Table 1. Demographic results.

	Radiochemotherapy	Radiotherapy
No. of patients	47	49
Age
Median	58	59
Range	34–75	42–75
Male/female	32/15	30/19
Primary site of tumour
NSCLC first line	7	8
NSCLC recurrence	24	24
SCLC first line	3	2
SCLC recurrence	13	15
ECOG performance status
0	8	2
1	29	22
2	7	19
3	1	2
Not reported	2	4
No. of brain metastases >4
Yes	11	14
No	36	35
Extracerebral metastases
Yes	35	37
No	12	12
Dexamethasone dosing
Yes	38	39
Not	9	8
Not reported	0	2
Courses of continuation therapy
1	1	2
2	1	1
3	6	4